U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713694) titled 'The Impact of Culture in Cognitive Behavior Therapy (CBT) for Anxiety, with Inflammatory Bowel Disease' on Nov. 24.
Brief Summary: Introduction Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic condition that affects the gastrointestinal tract and has a significant impact on patients' quality of life (QoL) and mental health(Barberio, Zamani et al. 2021). Cognitive behavioral therapy (CBT) has been recognized as a potential therapeutic approach to address the psychological comorbidities associated with IBD(Seaton, Hudson et al. 2024). However, the effectiveness of CBT in IBD is not s...